Athanor Capital, LP Orchard Therapeutics PLC Transaction History

Athanor Capital, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$4.39 - $9.08 $150,594 - $311,480	-34,304 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.86 - $5.07 $132,413 - $173,921	34,304 New	34,304 $148,000
Q3 2020 Nov 16, 2020	SELL	$4.11 - $6.45 $177,325 - $278,285	-43,145 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$5.75 - $11.99 $248,083 - $517,308	43,145 New	43,145 $259,000
Q1 2020 May 14, 2020	SELL	$5.65 - $15.71 $128,820 - $358,188	-22,800 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$10.15 - $15.58 $5,075 - $7,790	-500 Reduced 2.15%	22,800 $314,000
Q3 2019 Nov 14, 2019	BUY	$11.88 - $16.72 $106,920 - $150,480	9,000 Added 62.94%	23,300 $277,000
Q2 2019 Aug 13, 2019	BUY	$13.2 - $20.63 $188,760 - $295,009	14,300 New	14,300 $200,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.